<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nitin Govindrao Dumore</style></author><author><style face="normal" font="default" size="100%">Milind Janrao Umekar</style></author><author><style face="normal" font="default" size="100%">Brijesh Gulabrao Taksande</style></author><author><style face="normal" font="default" size="100%">Manish Manohar Aglawe</style></author><author><style face="normal" font="default" size="100%">Nandkishor Ramdasji Kotagale</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Effects of Withania somnifera Nicotine Induced Conditioned Place Preference in Mice</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Condition place preference</style></keyword><keyword><style  face="normal" font="default" size="100%">Nicotine</style></keyword><keyword><style  face="normal" font="default" size="100%">Withania somnifera</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style  face="normal" font="default" size="100%">January 2019</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">11</style></volume><pages><style face="normal" font="default" size="100%">43-47</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt;&lt;strong&gt;Background:&lt;/strong&gt; Herbal medicines can be novel treatment strategies for management of nicotine addiction. Withania somnifera (Ashwagandha) is an Indian medicinal plant of great medicinal value; used in many clinically proven conditions. Objective: In present study we aimed at investigating the effect of withania somnifera extract (WSE) on preventing nicotine mediated effects attributed for the development of addiction. &lt;strong&gt;Material and Methods:&lt;/strong&gt; Mice were treated with nicotine and/or WSE and subjected to nicotine induced conditioned place preference (CPP) in male albino mice was checked.&lt;strong&gt; Results: &lt;/strong&gt;Application of two-way ANOVA showed that with preconditioning and post-conditioning values as a within-subjects (column) factor and treatment as an independent between subject (row) factor. Two-way ANOVA revealed significant effect of treatment [F(3,40)=4.119, p&amp;lt;0.05], time [F(1,40)=23.76, p&amp;lt;0.001] and interactiontreatment x time [F(3,40)=5.244, p&amp;lt;0.01] on Intra-peritoneal (ip) administration of nicotine (1 mg/kg). WSE did not produce any changes in the preference to drug-paired compartment. Factors like treatment [F(3,40) = 0.656, p&amp;gt;0.05], time [F(1,40) = 7.383, p&amp;lt;0.01] and interactiontreatment x time [F(3,40) = 0.5748, p&amp;gt;0.05] showed insignificant effects. Withania somnifera (50,100,200 mg/kg ip) coadministered with nicotine during the 6 days conditioning sessions completely abolished the acquisition of nicotine-induced CPP in mice. &lt;strong&gt;Conclusion:&lt;/strong&gt; Above data indicate that withania somnifera attenuate nicotine induced CPP. Hence it has potential as an anti-addictive therapy.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">1</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">43</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p&gt;&lt;strong&gt;Nitin Govindrao Dumore&lt;sup&gt;1,2*&lt;/sup&gt;, Milind Janrao Umekar&lt;sup&gt;1&lt;/sup&gt;, Brijesh GulabraoTaksande&lt;sup&gt;1&lt;/sup&gt;, Manish Manohar Aglawe&lt;sup&gt;1&lt;/sup&gt;, Nandkishor Ramdasji Kotagale&lt;sup&gt;3&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;1&lt;/sup&gt;Division of Neuroscience, Department of Pharmacology, Smt.kishoritai Bhoyar College of pharmacy Kamptee, Nagpur 441002 Maharashtra, INDIA.&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;2&lt;/sup&gt;Dadasaheb Balpande College of Pharmacy, Besa, Nagpur,440037 Maharashtra, INDIA.&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;3&lt;/sup&gt;Department of Pharmacognosy, Government college of Pharmacy, Amaravati, 444601, Maharashtra, INDIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nandkishor Ramdas Kotagale</style></author><author><style face="normal" font="default" size="100%">Ankit Kedia</style></author><author><style face="normal" font="default" size="100%">Rupali Gite</style></author><author><style face="normal" font="default" size="100%">Shubham Nilkanth Rahmatkar</style></author><author><style face="normal" font="default" size="100%">Dinesh Yugraj Gawande</style></author><author><style face="normal" font="default" size="100%">Milind Janraoji Umekar</style></author><author><style face="normal" font="default" size="100%">Brijesh Gulabrao Taksande</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Withaferin A attenuates Alcohol Abstinence Signs in Rats</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Anxiety</style></keyword><keyword><style  face="normal" font="default" size="100%">Corticosterone</style></keyword><keyword><style  face="normal" font="default" size="100%">Ethanol withdrawal</style></keyword><keyword><style  face="normal" font="default" size="100%">HPA axis</style></keyword><keyword><style  face="normal" font="default" size="100%">Withaferin A.</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style  face="normal" font="default" size="100%">August 2018</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">10</style></volume><pages><style face="normal" font="default" size="100%">1190-1195</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; &lt;em&gt;Withania somnifera&lt;/em&gt; (WS) have been reported to inhibit acquisition and expression conditioned place preference, self-administration and withdrawal anxiety of psychostimulants. In the present work, we have assessed the effect of withaferin A on somatic and affective symptoms of ethanol withdrawal syndrome in rats. &lt;strong&gt;Methods:&lt;/strong&gt; Animals had given free access to ethanol uninterrupted for 21 days through liquid diet. Withaferin A (5, 10 and 20 mg/kg) was injected (ip) either during the development of ethanol dependence phase (days 15 &amp;ndash; 21 or 30 min before ethanol withdrawal assessment. Withdrawal signs characterized by changes in somatic signs were measured in the open field followed by evaluation of anxiety parameters, locomotion, and depressive behavior. &lt;strong&gt;Results:&lt;/strong&gt; Withaferin A treatment 30 min before 24 h postethanol withdrawal assessment did not alter the scores of somatic behavioral signs in ethanol abstinence animals. However, withaferin A (10 and 20 mg/kg, ip) from day 15-21 prevented the ethanol withdrawal-induced elevated scores of somatic behaviors, hyperlocomotion, depressive behavior, and anxiety. Withaferin A treatment did not influence the blood ethanol levels in dependent and withdrawn animals. However, withaferin A administration attenuated the elevated plasma corticosterone and ACTH levels in ethanol-withdrawn rats, suggesting withaferin A induced anti-stress effect and stabilization of HPA axis activity could have facilitated the inhibitory effect of withaferin A on ethanol withdrawal syndrome. &lt;strong&gt;Conclusion:&lt;/strong&gt; The finding supports further investigation of withaferin A and other bioactive components of WS in alcohol addiction.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">6</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">1190</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Nandkishor Ramdas Kotagale, Ankit Kedia, Rupali Gite, Shubham Nilkanth Rahmatkar, Dinesh Yugraj Gawande, Milind Janraoji Umekar, Brijesh Gulabrao Taksande&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;Department of Pharmacology, Division of Neuroscience, Shrimati Kishoritai Bhoyar College of Pharmacy, New Kamptee, Nagpur (M.S.), INDIA.&lt;/p&gt;</style></auth-address></record></records></xml>